The analysis combines recent data, examples, and regulatory updates to give pharma professionals a clear, data-driven view of Lillys strategic lead in the new drug era of GLP-1
Recent Developments: Initiated Phase 3 trials for maritide (caftaglutide), targeting both GLP-1 and GIP receptors
Gastrointestinal symptoms and occasional psychiatric concerns require monitoring
Here's what patients say this kind of care can help with: "The first few weeks of GLP-1 treatment can bring a lot of change, which is why regular check-ins and a responsive care team are so important, explains Dr Zoe Lees (PhD), Medical Writer at Levity
Plainsboro, NJ: Novo Nordisk Inc
The company transformed a novel diabetes treatment into a weight-loss powerhouse, outperforming many rivals